Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 837

Similar articles for PubMed (Select 16635963)

2.

Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.

Lopatkin N, Sivkov A, Walther C, Schläfke S, Medvedev A, Avdeichuk J, Golubev G, Melnik K, Elenberger N, Engelmann U.

World J Urol. 2005 Jun;23(2):139-46. Epub 2005 Jun 1.

PMID:
15928959
3.

Phytotherapy for benign prostatic hyperplasia.

Wilt TJ, Ishani A, Rutks I, MacDonald R.

Public Health Nutr. 2000 Dec;3(4A):459-72.

PMID:
11276294
4.

Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.

Lopatkin N, Sivkov A, Schläfke S, Funk P, Medvedev A, Engelmann U.

Int Urol Nephrol. 2007;39(4):1137-46. Epub 2007 Feb 15.

PMID:
18038253
6.
8.

[Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial].

Lopatkin NA, Sivkov AV, Medvedev AA, Walter K, Schlefke S, Avdeĭchuk IuI, Golubev GV, Mel'nik KP, Elenberger NA, Engelman U.

Urologiia. 2006 Mar-Apr;(2):12, 14-9. Russian.

PMID:
16708583
9.

Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study.

Bechara A, Romano S, Casabé A, Haime S, Dedola P, Hernández C, Rey H.

J Sex Med. 2008 Sep;5(9):2170-8. doi: 10.1111/j.1743-6109.2008.00940.x. Epub 2008 Jul 14.

PMID:
18638006
10.
11.

A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter study.

Narayan P, Trachtenberg J, Lepor H, Debruyne FM, Tewari A, Stone N, Das S, Jimenez-Cruz JF, Shearer R, Klimberg I, Schellhammer PF, Costello AJ.

Urology. 1996 Apr;47(4):497-504.

PMID:
8638357
13.
14.

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study.

Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A.

Urology. 2003 Aug;62(2):259-64; discussion 264-5.

PMID:
12893330
16.

Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.

O'Leary MP, Roehrborn C, Andriole G, Nickel C, Boyle P, Höfner K.

BJU Int. 2003 Aug;92(3):262-6.

PMID:
12887480
17.

Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms.

Gerber GS, Zagaja GP, Bales GT, Chodak GW, Contreras BA.

Urology. 1998 Jun;51(6):1003-7.

PMID:
9609640
19.

[Comparison of different drugs on the treatment of benign prostate hyperplasia].

Li NC, Wu SL, Jin J, Qiu SP, Kong CZ, Song YS, Ye ZQ, Sun G, Sun YH, Sun YC, Wang XF, Na YQ.

Zhonghua Wai Ke Za Zhi. 2007 Jul 15;45(14):947-50. Chinese.

PMID:
17961376
20.

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E.

Eur Urol. 2008 Jun;53(6):1236-44. doi: 10.1016/j.eururo.2008.01.075. Epub 2008 Feb 4.

PMID:
18281145
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk